key: cord-0757456-feypwo64 authors: Singh, Jyoti; Jha, Monika; Metri, Kashinath; Mohanty, Sriloy; Singh, Amit; Tekur, Padmini title: "A study protocol for a randomised controlled trial on the efficacy of yoga as an adjuvant therapy for patients with Ankylosing spondylitis amidst COVID-19 pandemic"() date: 2021-11-21 journal: Adv Integr Med DOI: 10.1016/j.aimed.2021.11.001 sha: 901717592508e11ac0ac1b702cf59d40a2bd5304 doc_id: 757456 cord_uid: feypwo64 BACKGROUND: Amidst the adversities of the COVID 19 pandemic, the health care system has seen a new paradigm shift towards e-health services. In the advent of catering to the geometrically increasing health care needs of the patients suffering from various chronic health conditions when in social isolation, the need for the shift seems to be paramount. Patients with Ankylosing spondylitis under immunosuppressants and variable degrees of disabilities are at higher risk. This study aims to assess the efficacy of e-Yoga as a treatment option for these patients in need. METHODS: This is a single-center, parallel-group prospective randomized, open-blinded end-point trial. Patients aged between 30 to 50 years will be recruited from the members of Antardhwani: A society of ankylosing spondylitis, Ahmedabad, Gujarat. The yoga experts will administer a scientifically developed and validated Yoga module via e-Yoga modalities. A total of 135 patients will be recruited and randomly allocated to Yoga and control groups. Data will be recorded at baseline and three months on disease activity, degree of functional limitations in patients, quality of life, inflammatory biomarkers, depression, and anxiety using Bath AS Disease Activity Index (BASDAI), Bath AS Functional Index(BASFI), AS Quality of Life index(ASQOL), C reactive protein (CRP), Erythrocyte sedimentation rate (ESR), Physical health questionnaire-4 (PHQ-4), respectively. DISCUSSION: The study will report the efficacy of e-Yoga in catering to the physical and mental insufficiencies of inpatients with Ankylosing spondylitis amidst Covid 19 pandemic. The study is prospectively registered in the Clinical Trial Registry of India (CTRI/2020/08/027215) When a third of the global population is still under social isolation, the COVID-19 infection hasbegun unfolding its catastrophic consequencesuponthe vulnerable population. "Stay Home, Stay Safe" may be a wide-reaching mitigation effort to control the outbreak, but it is proving that a home is not always heaven for vulnerable populations. Patients with underlying rheumatologic disorders and under immunosuppressant drugs are reported to be at higher risk. In addition, social distancing norms necessitating confinement have instigated physical inactivity, faulty dietary habits, psychological apprehensions, and poor management of co-morbidities resultant in exacerbation of the medical conditions. Ankylosing spondylitis J o u r n a l P r e -p r o o f (AS) is a chronic inflammatory disease with prevalence per 10,000 as 16.7 in Asia and a total number of cases ranging from 4.63 million -4.98 million. [1] It is an autoimmune disease marked by profound inflammation at the axial and sacroiliac joints. Patients with AS havea physical disability, poor work efficiency or unemployment, increased need for medical attention, psychological distress, and low quality of life. [1, 2] Although the exact pathology is unclear, a cascade of events linking HLA-B27, inflammatory markers, cytokines (TNF alpha and IL 10), genetic and environmental factors suggest autoimmune mechanisms behind its pathogenesis. [3] The management of AS involves administering anti-inflammatory drugs (NSAIDs), Corticosteroids, Disease-modifying antirheumatic drugs, etc.,with limited effect on the disease progression. A recent report highlighted the positive relationship between perceived COVID threat and psychological status with the disease activity among AS patients. [4] However, with emerging knowledge in this domain and new scientific technologies, it is noteworthy how the role of intervention such as exercise, physiotherapy, and mind-body medicine are delineating to be an efficient adjunct in treating AS. [5] [6]The previous study suggests an improvement in the Bath Ankylosing spondylitis disease activity index (BASDAI) by 32%,advocating the effectiveness of yoga and physiotherapy intervention in these patients. [7] Yoga, a mind-body medicine, has been observed to curtail chronic pain, functional disability, improve joint mobility, reduce inflammation, improve mental health and the overall quality of life. [8] [9][10] [11] However, the evidence for the effectiveness of Yoga-based intervention in patients is sparse. The present study is designed to impede this gap and depict the feasibility and efficacy of Yoga as a potent treatment modality for Ankylosing spondylitis amidst the COVID-19 Pandemic. J o u r n a l P r e -p r o o f Approximately 135 patients with ankylosing spondylitis will be randomized in a 1:1 allocation ratio inthe study and control groups. The study group will receive a 60minuteonline yoga-based interventionand the standard care for AS, whereas the control group will receive standard care only. The study aims to evaluatepain, quality of life, spinal flexibility, disability, and inflammatory markers in patients with ankylosing spondylitis at baseline and three months post-randomization. The protocol of the study is drafted following the Standard Protocol Items: Recommendations for Interventional Trials. [12] The Institutional ethics committee approves the study, and the study is prospectively registered in the Clinical Trial Registry of India (CTRI/2020/08/027215) The trial will be a single-center, parallel-group prospective randomized, open-blinded endpoint trial (PROBE) to evaluate Yoga-based intervention's efficacyamongpatients with Ankylosing spondylitis. ( Figure. 1 Trial profile). The patients will be recruited from the pool of members of Antardhwani:An Ankylosing spondylitissociety, Ahmedabad, Gujarat working towards management of AS. The intervention was designed to be given virtually in the form of e-Yoga by the Yoga experts at SVYASA, Bangalore. The researchers will administer the assessments at baseline and three months through online mode. Patients aged between 30-50 years, both genders with a minimum AS history for three years and fulfilling the New York's criteria for Ankylosing spondylitis [13] , will be recruited. Each participant practicing Yoga before the recruitment in the study (h) Patients with a psychiatric diagnosis. Eligible patients providing informed consent will be randomized into two groups with an allocation ratio of 1:1, i.e., the Intervention and Control arm. The sample size was calculated using G power software as 108 (Yoga=54; Control=54). The effect size taken was 0.63 from previous studies and fixing α = 0.05. [14] With a power of the study considered 0.90anda dropoutrate of 20%, a total sample size of 135subjects was calculated for the current trial. The intervention group will be taught yoga practices additionally by institutionally trained andcertified yoga therapists with over five years of experience through e-health modalities (online video classes). The standard medical care will be continued for all the patients during the study period. The current yoga module was developed keeping in mind the COVID 19 pandemic and following focused group discussions between our multidisciplinary team, including experts from Rheumatology,Physiotherapy, Medicine,and Yogic sciences, based on the pathophysiological mechanisms involved in disease causation, progression, and the availableliterature in Yoga. Later the protocol was also validated by the Yoga professionals of different schools across India. The yoga module comprises a combination of Yoga postures, breathing practices, meditative techniques, and relaxation. (Table. 1) The physical postures consist of preliminary stretching exercises followed by breathing exercises and then by Asana in four categories (standing, sitting, prone, and supine) followed by Pranayama. It provides a moderate intensity of J o u r n a l P r e -p r o o f physical activity. The patients will be instructed to follow a specific breathing pattern, culminating in a relaxation response during the practice. The practices are well spaced by relaxation techniques to avoid any strain or exhaustion to the patients. No substantial modifications were needed in the yoga module while teaching the practices to the patients as the module was developed, keeping in mind their needs and condition. During the study duration, the subjects will be contacted by the researcher, assessed, and randomized. Following which the intervention group will undergo online yoga sessions four times a week for 60 minutes each for three months. Each session will have a pre-planned, validated yoga protocol which will be rendered to the patients by the yoga experts. During the non-contact period, the subjects will be encouraged and motivated to practice the yoga protocol for the remaining days at home three times a week for 60 minutes during the study. Video of the complete session and picture-based modules will be given to assist the homebased practices. Besides, each patient, irrespective of their group allocation, will be provideda booklet explaining the disease, prognosis, details of the yoga module, and its health benefits pictorially. In addition, a logbook will be given to all recruited participants to record their practice at home, including the duration and time of practice, additional physical activities, and medication intake to document their adherence.The consultants viewed 10 % of the videotaped sessions and reported satisfactory fidelity towards the intervention administration. Thetrial's objective is to evaluate the effect of yoga-based intervention as an adjuvant to the Each subject and the accompanying family members will be educated regarding the risks and disabilities related to the progression of the disease. The control group will be advised to continue the standard medical care for the same duration, i.e., three months. In addition, an educational session pertaining to the significance of medication, additional physical activity, dietary changes, etc., will be conducted at baseline. The control group will also be provided with a logbook to record their physical activities and medications intake. Participants will be withdrawn from the trial if they acquire COVID-19 infection as it may cause a cytokine storm. In addition, the subjects will not be able to follow the protocol as well, as it may bring changes to the trial's objectives. All subjects will be randomized into two groups,the Yoga group and the Control group,with an allocation ratio of 1:1. An independent statistician will generate a computerized unpredictable random number sequence using randomizer.org, who has no role in the current study. Further, sequentially numbered opaque sealed envelopes will be maintained by a person who is not a part of the study to maintain concealment. Blinding of the patients is not possible in this trial;however, the outcome assessor will be blinded. 3.4. Creactiveprotein: C-reactive protein (CRP) blood tests are commonly used to detect increased protein levels in the blood. CRP is valued clinically as a sensitive marker of inflammation. CRP Levels in young, healthy adults are usually less than ten mg/L, but more than that can increase response to infection or inflammation. [18] 3.5. A blood test commonly used to detect increased protein in the blood.If specific proteins cover red cells, these will stick to each other and cause the red cells to fall more quickly. So, a high ESR indicates inflammation somewhere in the body.Normal range is 0-22 mm/hour for men and 0-29 mm/hour for women. [19] 3.6. Patient Health Questionnaire-4:A four-item questionnaire used to briefly and accurately measure the core signs and symptoms of depression and anxiety. A score of 3 or more on depression and anxiety subscales identifies potential cases of depression and anxiety, respectively. [20] J o u r n a l P r e -p r o o f 3.7. Blood sample collection:Blood samples (5 ml) will be collected aseptically in the plain tube and standardizedlaboratory procedures for hs-CRP and ESR. The samples will be collected before the intervention commencement (Day of randomization ± seven days) and after three months (3 months ± seven days) of baseline data collection. Baseline participant characteristics of both the group will be presented. The normality of the variables will be assessed using the skewness statistic and normal probability plot, based on which appropriate parametric or nonparametric tests will be used. Follow-up data at three months will be explored through linear mixed models utilizing repeated measures analyses, allowing simultaneous modeling of the two outcome time points. Subgroup analyses will be done based on groups, adherence to the intervention, and other clinical data. An intention-totreat analysis will be conducted along with a separate per-protocol analysis, as adherence may be sub-optimal. All statistical tests will be two-tailed and statistical significance will be set at 0.05. The final report will follow the CONSORT 2010 guidelines as well as its extension to non-pharmacological interventions. [21] [22] The trial was initiated in April 2020 amidst the covid-19 Pandemic. The protocol was amended as per the Indian Council of Medical Research Guidelines for research guidelines during COVID-19. [23] The contactsessions were converted into online sessions. The followup was also done in online mode, and the investigators took blood samples from home. Additionally, biweekly calls were also made to improve adherence during the non-contact period. Patients infected with COVID-19 will be excluded from the trial as they may have an additional cytokine storm, leading to changes in the CRP and ESR. J o u r n a l P r e -p r o o f The current study is the first study to explore the effect of Yoga rehabilitation on the physical functioning and psychological wellbeing of patients with AS amidst the COVID-19 Pandemiccompared to a control group. In this report, we have highlighted the design of the acknowledged, including complete online sessions, which was a must to conduct the study amidst the Pandemic, (2) the study did not involve any inflammatory cytokines, which might have given a detailed understanding of the efficacy of Yoga. In the current study, the recruitment of the patients is expected to be completed by April 2022. The results will be reported in the scientific media through research articles and conferences. The preliminary results will be available from the corresponding author on reasonable request. The details of the individual patient will be kept confidential. Research ethics approval: The trial was submitted and approved by the institutional ethics committee at SVYASA University. No amendments were made in the protocol. Consent or assent: Consent forms were signed by the subjects before the recruitment in the study. Global prevalence of ankylosing spondylitis, Rheumatol ASAS/EULAR recommendations for the management of ankylosing spondylitis Ankylosing spondylitis: An overview Effects of the COVID-19 Pandemic on psychology and disease activity in patients with ankylosing spondylitis and rheumatoid arthritis Long-term effectiveness of physiotherapy in a case of ankylosing spondylitis Yoga compared to nonexercise or physical therapy exercise on pain, disability, and quality of life for patients with chronic low back pain: A systematic review and meta-analysis of randomized controlled trials Gravity Based and Core Strengthening Exercises on Ankylosing Spondylitis -An Evidence Based Study Mediators of Yoga and stretching for chronic low back pain, Evidence-Based Complement Effect of Yoga on pain, brain-derived neurotrophic factor, and serotonin in premenopausal women with chronic low back pain, Evidence-Based Complement A Systematic Review and Meta-analysis of Yoga for Low Back Pain Effect of Short-Term Intensive Yoga Program on Pain, Functional Disability and Spinal Flexibility in Chronic Low Back Pain: A Randomized Control Study SPIRIT 2013: New guidance for content of clinical trial protocols A. Cats, Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria The Effect of Breathing and Posture Exercise on the Clinical, Functional Status and Disease Related Quality of Life in Patients with Ankylosing Spondylitis A new approach to defining disease status in ankylosing spondylitis: The bath ankylosing spondylitis disease activity index Comparison of the Dougados Functional Index and the Bath Ankylosing Spondylitis Functional Index. A literature review Development of the ASQoL: A quality of life instrument specific to ankylosing spondylitis C-reactive protein: a critical update Erythrocyte sedimentation rate. From folklore to facts An Ultra-Brief Screening Scale for Anxiety and Depression: The PHQ-4 Extending the CONSORT Statement to Randomized Trials of Nonpharmacologic Treatment: Explanation and Elaboration Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials National Guidelines for ethics committees reviewing biomedical and health research during COVID-19 Pandemic Ethical Statement: The authors declare that the trial is ethically approved, and consent from the participant will be obtained Conflict of Interest: The authors declare no conflict of interests.Authors Statement: On behalf of all the authors, I state that all the queries raised by the reviewers and the editors has been addressed.